Phase IV trial of CSL's influenza virus vaccine administered with the Stratis needle-free jet injector system

Trial Profile

Phase IV trial of CSL's influenza virus vaccine administered with the Stratis needle-free jet injector system

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2014

At a glance

  • Drugs Influenza virus vaccine (Afluria) (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Most Recent Events

    • 19 Aug 2014 The US FDA approved the PharmaJet Stratis 0.5mL needle-free jet injector for delivery of influenza vaccine in individuals aged 18-64 years, based on the results of this trial, according to a PharmaJet media release.
    • 03 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top